HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART)
Introduction: As patients with HIV live longer due to Combination Anti-Retroviral Therapy (cART) serostatus disclosure becomes an important issue. Disclosure can have both positive and negative outcomes. Disclosure of HIV status has been associated with better adherence to medication and reducti...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2015-08-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/articles/PDF/6373/12511_CE(RA1)_F(T)_PF1(VSUAK)_PFA(AK)_PF2(PAG).pdf |
| _version_ | 1818151096328126464 |
|---|---|
| author | Deepak Madi Parul Gupta Basavaprabhu Achappa Unnikrishnan Bhaskaran John T. Ramapuram Satish Rao Soundarya Mahalingam |
| author_facet | Deepak Madi Parul Gupta Basavaprabhu Achappa Unnikrishnan Bhaskaran John T. Ramapuram Satish Rao Soundarya Mahalingam |
| author_sort | Deepak Madi |
| collection | DOAJ |
| description | Introduction: As patients with HIV live longer due to Combination
Anti-Retroviral Therapy (cART) serostatus disclosure becomes an
important issue. Disclosure can have both positive and negative
outcomes. Disclosure of HIV status has been associated with better
adherence to medication and reduction in levels of psychological
distress. Stigma and disruption of family relationships are barriers
for disclosure. Most studies regarding disclosure status have been
conducted in West. There are many cultural differences in Indian
society when compared to west. There is a dearth of research in
the field of disclosure of HIV infection in India.
Aim: To determine the prevalence of HIV status disclosure among
people living with HIV (PLHIV) in South India.
Materials and Methods: This descriptive cross-sectional study
was done in the hospital attached to Kasturba Medical College
(KMC), Mangalore, India from May–June 2013. PLHIV of age
more than 18 years were included. During the study period 111
consecutive patients who consented for the study were enrolled.
Statistical Analysis: Data was collected using a pre-tested
interviewer administered semi structured questionnaire. Data
collected was analysed using SPSS Version 11.5 statistical
software. Descriptive statistics were done and the results are
presented as proportions and mean.
Results: The mean age of the study population was 44.86 ± 10.8
years. Majority of the study subjects were men 76 (68.4%). Out of
111 study subjects, 102 (91.9%) had disclosed their HIV status
to at least one person while 9 (8.1%) had not disclosed their HIV
status to anyone. Disclosure on doctor’s advice was the main
reason for 56 (54.9%) participants to disclose their HIV status. The
main reason for non-disclosure was fear of shame in family.
Conclusion: Disclosure rate was high in our study in the era of
cART. Society must stop discriminating against PLHIV so that
they can disclose their serostatus and gain access to care and
treatment services without any fear of stigma. In our study the main
reason for disclosure was doctor’s advice which clearly states the
importance of the commitment of doctors in creating awareness
among PLHIV about the need for voluntary disclosure. |
| first_indexed | 2024-12-11T13:33:23Z |
| format | Article |
| id | doaj.art-0a7e6e61aff24222824421b003ea5777 |
| institution | Directory Open Access Journal |
| issn | 2249-782X 0973-709X |
| language | English |
| last_indexed | 2024-12-11T13:33:23Z |
| publishDate | 2015-08-01 |
| publisher | JCDR Research and Publications Private Limited |
| record_format | Article |
| series | Journal of Clinical and Diagnostic Research |
| spelling | doaj.art-0a7e6e61aff24222824421b003ea57772022-12-22T01:05:09ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2015-08-0198OC14OC1610.7860/JCDR/2015/12511.6373HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART)Deepak Madi0Parul Gupta1Basavaprabhu Achappa2Unnikrishnan Bhaskaran3John T. Ramapuram4Satish Rao5Soundarya Mahalingam6Associate Professor, Department of Internal Medicine, Kasturba Medical college, Mangalore. Affiliated to Manipal University, Mangalore, India.Undergraduate Student, Kasturba Medical College, Mangalore. Affiliated to Manipal University, Mangalore, India.Associate Professor, Department of Internal Medicine, Kasturba Medical College, Mangalore. Affiliated to Manipal University, Mangalore, India.Professor and Head, Department of Community Medicine, Kasturba Medical College, Mangalore, Affiliated to Manipal University, Mangalore, India.Professor, Department of Internal Medicine, Kasturba Medical College, Mangalore. Affiliated to Manipal University, Mangalore, India.Additional Professor, Department of Internal Medicine, Kasturba Medical College, Mangalore. Affiliated to Manipal University, Mangalore, India.Associate Professor, Department of Paediatrics, Kasturba Medical College, Mangalore. Affiliated to Manipal University, Mangalore, India.Introduction: As patients with HIV live longer due to Combination Anti-Retroviral Therapy (cART) serostatus disclosure becomes an important issue. Disclosure can have both positive and negative outcomes. Disclosure of HIV status has been associated with better adherence to medication and reduction in levels of psychological distress. Stigma and disruption of family relationships are barriers for disclosure. Most studies regarding disclosure status have been conducted in West. There are many cultural differences in Indian society when compared to west. There is a dearth of research in the field of disclosure of HIV infection in India. Aim: To determine the prevalence of HIV status disclosure among people living with HIV (PLHIV) in South India. Materials and Methods: This descriptive cross-sectional study was done in the hospital attached to Kasturba Medical College (KMC), Mangalore, India from May–June 2013. PLHIV of age more than 18 years were included. During the study period 111 consecutive patients who consented for the study were enrolled. Statistical Analysis: Data was collected using a pre-tested interviewer administered semi structured questionnaire. Data collected was analysed using SPSS Version 11.5 statistical software. Descriptive statistics were done and the results are presented as proportions and mean. Results: The mean age of the study population was 44.86 ± 10.8 years. Majority of the study subjects were men 76 (68.4%). Out of 111 study subjects, 102 (91.9%) had disclosed their HIV status to at least one person while 9 (8.1%) had not disclosed their HIV status to anyone. Disclosure on doctor’s advice was the main reason for 56 (54.9%) participants to disclose their HIV status. The main reason for non-disclosure was fear of shame in family. Conclusion: Disclosure rate was high in our study in the era of cART. Society must stop discriminating against PLHIV so that they can disclose their serostatus and gain access to care and treatment services without any fear of stigma. In our study the main reason for disclosure was doctor’s advice which clearly states the importance of the commitment of doctors in creating awareness among PLHIV about the need for voluntary disclosure.https://jcdr.net/articles/PDF/6373/12511_CE(RA1)_F(T)_PF1(VSUAK)_PFA(AK)_PF2(PAG).pdfdiscriminationplhivserostatus |
| spellingShingle | Deepak Madi Parul Gupta Basavaprabhu Achappa Unnikrishnan Bhaskaran John T. Ramapuram Satish Rao Soundarya Mahalingam HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART) Journal of Clinical and Diagnostic Research discrimination plhiv serostatus |
| title | HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART) |
| title_full | HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART) |
| title_fullStr | HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART) |
| title_full_unstemmed | HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART) |
| title_short | HIV Status Disclosure Among People Living with HIV in the Era of Combination Antiretroviral Therapy (cART) |
| title_sort | hiv status disclosure among people living with hiv in the era of combination antiretroviral therapy cart |
| topic | discrimination plhiv serostatus |
| url | https://jcdr.net/articles/PDF/6373/12511_CE(RA1)_F(T)_PF1(VSUAK)_PFA(AK)_PF2(PAG).pdf |
| work_keys_str_mv | AT deepakmadi hivstatusdisclosureamongpeoplelivingwithhivintheeraofcombinationantiretroviraltherapycart AT parulgupta hivstatusdisclosureamongpeoplelivingwithhivintheeraofcombinationantiretroviraltherapycart AT basavaprabhuachappa hivstatusdisclosureamongpeoplelivingwithhivintheeraofcombinationantiretroviraltherapycart AT unnikrishnanbhaskaran hivstatusdisclosureamongpeoplelivingwithhivintheeraofcombinationantiretroviraltherapycart AT johntramapuram hivstatusdisclosureamongpeoplelivingwithhivintheeraofcombinationantiretroviraltherapycart AT satishrao hivstatusdisclosureamongpeoplelivingwithhivintheeraofcombinationantiretroviraltherapycart AT soundaryamahalingam hivstatusdisclosureamongpeoplelivingwithhivintheeraofcombinationantiretroviraltherapycart |